BrainsWay Ltd (BrainsWay) is a medical technology company focused on developing advanced noninvasive neurostimulation treatments for mental health disorders. The company carries out the research, development, and commercialization of medical devices that utilize Deep Transcranial Magnetic Stimulation (Deep TMS) technology. BrainsWay's major products include devices for the treatment of major depressive disorder, obsessive-compulsive disorder, and smoking addiction. Its products are used by healthcare providers to treat patients with mental health conditions. It operates with offices in the US and Israel. Brainsway is headquartered in Jerusalem, Israel.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Brainsway Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Brainsway Ltd Company Overview
- Brainsway Ltd Company Snapshot
- Brainsway Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Brainsway Ltd - Pipeline Analysis Overview
- Brainsway Ltd - Key Facts
- Brainsway Ltd - Major Products and Services
- Brainsway Ltd Pipeline Products by Development Stage
- Brainsway Ltd Ongoing Clinical Trials by Trial Status
- Brainsway Ltd Pipeline Products Overview
- Deep TMS 360 System - Alcohol Use Disorder
- Deep TMS 360 System - Alcohol Use Disorder Product Overview
- Deep TMS 360 System - Alcohol Use Disorder Clinical Trial
- Deep TMS System - Accelerated Depression
- Deep TMS System - Accelerated Depression Product Overview
- Deep TMS System - Alzheimer's Disease
- Deep TMS System - Alzheimer's Disease Product Overview
- Deep TMS System - Bipolar Disorder
- Deep TMS System - Bipolar Disorder Product Overview
- Deep TMS System - Chronic Pain
- Deep TMS System - Chronic Pain Product Overview
- Deep TMS System - Obesity
- Deep TMS System - Obesity Product Overview
- Deep TMS System - Obesity Clinical Trial
- Deep TMS System - Opioid Use Disorder
- Deep TMS System - Opioid Use Disorder Product Overview
- Deep TMS System - Post-Stroke
- Deep TMS System - Post-Stroke Product Overview
- Deep TMS System - PTSD
- Deep TMS System - PTSD Product Overview
- Next-Generation Multi-Channel TMS Stimulator
- Next-Generation Multi-Channel TMS Stimulator Product Overview
- Rotational Field TMS System
- Rotational Field TMS System Product Overview
- Rotational Field TMS System Clinical Trial
- Brainsway Ltd - Key Competitors
- Brainsway Ltd - Key Employees
- Brainsway Ltd - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Brainsway Ltd, Recent Developments
- Apr 15, 2026: Brainsway Highlights Growing U.S. Payer Support for Nurse Practitioner-Administered Transcranial Magnetic Stimulation (TMS) Therapy
- Mar 13, 2026: Radial Announces Publication of Landmark Study of Accelerated Deep TMS for Depression
- Mar 04, 2026: Landmark Data Validate BrainsWay’s SWIFT Deep TMS, Beginning a New Era in Depression Treatment
- Feb 18, 2026: BrainsWay Reports Cigna’s Evernorth Behavioral Health to Eliminate Prior Authorization Requirements for TMS Coverage, Accelerating Access to Care
- Jan 21, 2026: BrainsWay Announces Draft Coverage Policy from Highmark for Accelerated Deep TMS
- Jan 12, 2026: Brainsway Announces FDA Approval of Neurolief’s Proliv Rx Neuromodulation System for Major Depressive Disorder (MDD)
- Jan 07, 2026: BrainsWay Announces First Coverage Policy for Accelerated Deep TMS
- Dec 22, 2025: Brainsway Reports Expansion of Adolescent Depression Coverage Applicable to Deep TMS
- Nov 18, 2025: Brainsway Receives the Additional FDA 510(k) Clearance for H7 Deep TMS System
- Nov 17, 2025: BrainsWay Launches First Clinical Trial of Deep TMS 360 System for Alcohol Use Disorder
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Brainsway Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Brainsway Ltd Pipeline Products by Equipment Type
- Brainsway Ltd Pipeline Products by Indication
- Brainsway Ltd Ongoing Clinical Trials by Trial Status
- Brainsway Ltd, Key Facts
- Brainsway Ltd, Major Products and Services
- Brainsway Ltd Number of Pipeline Products by Development Stage
- Brainsway Ltd Pipeline Products Summary by Development Stage
- Brainsway Ltd Ongoing Clinical Trials by Trial Status
- Brainsway Ltd Ongoing Clinical Trials Summary
- Deep TMS 360 System - Alcohol Use Disorder - Product Status
- Deep TMS 360 System - Alcohol Use Disorder - Product Description
- Deep TMS 360 System - Alcohol Use Disorder - A Prospective, Double Blind, Randomized, Controlled Study to Evaluate the Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment of Alcohol Use Disorder (AUD)
- Deep TMS System - Accelerated Depression - Product Status
- Deep TMS System - Accelerated Depression - Product Description
- Deep TMS System - Alzheimer's Disease - Product Status
- Deep TMS System - Alzheimer's Disease - Product Description
- Deep TMS System - Bipolar Disorder - Product Status
- Deep TMS System - Bipolar Disorder - Product Description
- Deep TMS System - Chronic Pain - Product Status
- Deep TMS System - Chronic Pain - Product Description
- Deep TMS System - Obesity - Product Status
- Deep TMS System - Obesity - Product Description
- Deep TMS System - Obesity - Deep Transcranial Magnetic Stimulation (dTMS) of the Medial Prefrontal Cortex (mPFC) in Food Addiction and Obesity
- Deep TMS System - Opioid Use Disorder - Product Status
- Deep TMS System - Opioid Use Disorder - Product Description
- Deep TMS System - Post-Stroke - Product Status
- Deep TMS System - Post-Stroke - Product Description
- Deep TMS System - PTSD - Product Status
- Deep TMS System - PTSD - Product Description
- Next-Generation Multi-Channel TMS Stimulator - Product Status
- Next-Generation Multi-Channel TMS Stimulator - Product Description
- Rotational Field TMS System - Product Status
- Rotational Field TMS System - Product Description
- Rotational Field TMS System - The Clinical Study to Assess the Safety and Efficacy of Rotational Field TMS System in Rehabilitation Following Stroke
- Brainsway Ltd, Key Employees
- Brainsway Ltd, Subsidiaries
- Glossary
- Brainsway Ltd Pipeline Products by Equipment Type
- Brainsway Ltd Pipeline Products by Development Stage
- Brainsway Ltd Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- InterCure Ltd
- Neurolief Ltd.
- BrainQ Technologies Ltd
